Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study.
Human research record. Stroke, 2025.
- Human
- 2025
Authorship
Exact sentences from the abstract. No machine-written text is on this page. No person reviewed it.
Source: the abstract of PMID 39957612. Checked Verification: Evidence verified by machine against declared source
This study and its findings belong to the authors cited. Defiance International, a supplier of chemical sequences for research use, keeps this record and makes no claim from its findings.
Evidence verified by machine against declared source
Key facts
- Design
- Not reported
- System
- Human
- Scale
- Not published. Nothing is shown here and nothing is substituted for it.
- Comparator
- None reported
- Journal
- Stroke
- Year
- 2025
- PMID
- 39957612
- Verification
- Evidence verified by machine against declared source The stored extraction was checked against its declared source. Public summary availability is separate. No tier is an endorsement, an evidence-strength rating, or independent replication, and none establishes efficacy, safety, or suitability.
- Full-text availability
- Abstract only
Technical summary
Study design
The ESCAS study was an exploratory, prospective, randomized-controlled, double-blinded, academic study designed to assess the efficacy and safety of Cerebrolysin in combination with speech therapy compared with a placebo (saline solution) in combination with speech therapy for the treatment of nonfluent aphasia following acute ischemic stroke.
Not reported in the declared source: Methods, Key findings. Not published in this record: Research question, Participants or experimental system, Study scale, Intervention or exposure, Comparator, Outcomes examined, Key findings.
Limitations and uncertainty
Not published. Nothing is shown here and nothing is substituted for it.
Cite
Cite the study
Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study.
Homberg V, Jianu DC, Stan A et al. Stroke. 2025. PMID 39957612
The study and its abstract belong to their authors and publisher. Cite them for anything the study found.
Report an error
If a sentence on this record does not match the abstract, tell us which one. A report starts an automatic re-check by machine. No person reads the record first.
The form takes a sentence and your note. It asks for no name and no address, and we store neither. Do not put personal details in the note.
The report form runs in the interactive page. Open this record with scripts enabled to send a report.
Corrections on this record
No correction has been recorded for this record.
Method sheet
No machine-drafted summary is published on this record. Any section shown is the abstract’s own sentence, printed as issued.